Biovet S.A. organizará una nueva edición del Simposium Internacional de Biovet en la Cámara de Comercio de Tarragona el próximo 12 y 13 de mayo de 2022.
Alquerfeed Antitox, mycotoxin binder of Biovet S.A., patented worldwide in 1988, has been proved effective throughout its more than 30 years on the market in all species and productive aptitudes. Several experimental and field trials confirm that it is a product useful for poultry, including broilers and laying hens, and even in less common species such as turkeys; as well as in pig farming, where it is used both in breeders and fattening pigs.
On November 6, Biovet S.A. will present at Gut Health Symposium the results of the trial ‘Use of Alquernat Zycox as an effective manner to control induced coccidiosis in poultry’. This symposium is dedicated to animal welfare in animal production and especially in the essential role played by the intestine.
Emily Branstad, presented a scientific poster on “Supplementation with Alquerfeed Antitox for the reduction of aflatoxin M1 in milk and biomarkers of liver function in dairy cows”, at the annual meeting of the American Dairy Science Association (ADSA).
The aim of this trial, conducted at Iowa State University (EE.UU), was to evaluate the reduction in aflatoxin absorption upon feeding with Alquerfeed Antitox, to prevent absorption by binding AF in the digestive tract. Absorption is estimated from AFM1 concentration in milk.
The XXV Central American and Caribbean Poultry Congress will be held from August 21 to 23 in San Pedro Sula (Honduras). Biovet S.A. will participate with a stand N5 and present company product lines: preservatives, pronutrients and mycotoxin binders.